Equities research analysts forecast that Alliqua Biomedical Inc (NASDAQ:ALQA) will report ($0.55) earnings per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Alliqua Biomedical’s earnings. Alliqua Biomedical posted earnings of ($6.10) per share during the same quarter last year, which indicates a positive year-over-year growth rate of 91%. The firm is scheduled to report its next quarterly earnings results on Tuesday, March 6th.
On average, analysts expect that Alliqua Biomedical will report full-year earnings of ($3.85) per share for the current fiscal year. For the next year, analysts forecast that the firm will report earnings of ($1.19) per share. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research analysts that cover Alliqua Biomedical.
Several research firms recently issued reports on ALQA. Zacks Investment Research cut Alliqua Biomedical from a “buy” rating to a “hold” rating in a report on Wednesday, September 20th. HC Wainwright cut Alliqua Biomedical from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $4.50 to $2.80 in a report on Monday. Finally, ValuEngine upgraded Alliqua Biomedical from a “sell” rating to a “hold” rating in a report on Friday, October 6th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $8.20.
Alliqua Biomedical (NASDAQ ALQA) traded down $0.59 during trading hours on Friday, hitting $1.93. The stock had a trading volume of 779,000 shares, compared to its average volume of 350,880. Alliqua Biomedical has a 52-week low of $1.73 and a 52-week high of $8.50. The firm has a market cap of $9.62, a PE ratio of -0.20 and a beta of 1.85.
COPYRIGHT VIOLATION NOTICE: “-$0.55 Earnings Per Share Expected for Alliqua Biomedical Inc (ALQA) This Quarter” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/01/0-55-earnings-per-share-expected-for-alliqua-biomedical-inc-alqa-this-quarter.html.
About Alliqua Biomedical
Alliqua BioMedical, Inc is a provider of advanced wound care solutions. The Company’s businesses include advanced wound care and contract manufacturing. The Company operates through its subsidiaries, such as AquaMed Technologies, Inc and Choice Therapeutics, Inc The Company is engaged in developing a suite of advanced wound care solutions that will enable surgeons, clinicians and wound care practitioners to address the challenges in chronic and acute wounds.
Get a free copy of the Zacks research report on Alliqua Biomedical (ALQA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alliqua Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliqua Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.